Groesbeck Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$4.92M |
| 2 |
Cisco
CSCO
|
+$4.22M |
| 3 |
Johnson Controls International
JCI
|
+$4.1M |
| 4 |
Cracker Barrel
CBRL
|
+$3.5M |
| 5 |
Lazard
LAZ
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$5.07M |
| 2 |
Visa
V
|
+$4.97M |
| 3 |
Apple
AAPL
|
+$4.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$3.7M |
| 5 |
AT&T
T
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.44% |
| 2 | Financials | 17.85% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Industrials | 11.75% |
| 5 | Energy | 10.2% |
Similar funds
Groesbeck Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, Groesbeck Investment Management held 93 positions worth $137M, down 2% from $140M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Groesbeck Investment Management withdrew a net $4.64M in Q2 2016, closing 12 positions and reducing 38 holdings. Its most notable exit was AT&T, an estimated $2.94M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Groesbeck Investment Management opened a new position in MetLife worth $4.48M.
- Groesbeck Investment Management's largest Q2 2016 buy was MetLife: 126,105 shares worth $4.48M.
- Groesbeck Investment Management added most to Cisco in Q2 2016, an estimated $4.22M increase.
- Groesbeck Investment Management's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $5.07M.
- Groesbeck Investment Management fully exited AT&T in Q2 2016, selling an estimated $2.94M.
- Groesbeck Investment Management's ten largest holdings make up 36% of its $137M portfolio in Q2 2016.
- Groesbeck Investment Management opened 14 new positions and closed 12 in Q2 2016.
- Groesbeck Investment Management's portfolio value fell 2% quarter-over-quarter to $137M.
Based on Groesbeck Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.